Effect of immune checkpoint inhibitor infusion timing on overall survival in non–small cell lung cancer: A real-world retrospective study. This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results